St Andrews Turns Science into New Drugs
The Biomedical Sciences Research Complex (BSRC) at St Andrews has several projects where high-quality basic science is being turned into promising leads for new therapies. Three examples will be discussed anew:
- Antibiotics from enzyme mechanism studies;
- New anti-parasitic compounds from new synthetic chemistry, and ;
- A novel class of biological molecules from protein engineering.
The talk will highlight the longer term goals of the BSRC in bringing together scientists from different disciplines to work at problems that affect human health.
Jim Naismith is Professor of Chemical Biology, and the director of the Biomedical Sciences Research Complex (BSRC) at the University of St Andrews, as well as a member of the University Court.
Naismith was elected a Fellow of the Royal Society (FRS) in 2014. He is also Fellow of the Royal Society of Chemistry (FRSC), the Society of Biology (FSB), the Royal Society of Edinburgh (FRSE), the Academy of Medical Sciences (FMedSci) and an elected member of the European Molecular Biology Organization (EMBO).
His research has been funded by the Biotechnology and Biological Sciences Research Council (BBSRC), the Engineering and Physical Sciences Research Council (EPSRC), the Medical Research Council (MRC), the Wellcome Trust and the European Union.
Please join fellow St Andrews graduates, parents and friends for this insightful and thought-provoking discussion with Jim Naismith, Professor of Chemical Biology at the University of St Andrews.
This event is generously hosted by Robert and Mary-Louise Sinclair.